Cesar L. Avila

San Miguel De Tucuman, T, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Levodopa-Induced dyskinesia in Latin America: Prevalence and associated clinical factors in the LARGE-PD cohort.

Levodopa-Induced dyskinesia in Latin America: Prevalence and associated clinical factors in the LARGE-PD cohort.

Journal: Journal of Parkinson's disease

Published: April 17, 2026

Structure-Based Selection of a Tetracycline Derivative for Advanced Biosensor Platforms Targeting Aggregated α-Synuclein in Parkinson's Disease.

Structure-Based Selection of a Tetracycline Derivative for Advanced Biosensor Platforms Targeting Aggregated α-Synuclein in Parkinson's Disease.

Journal: ACS chemical neuroscience

Published: January 30, 2026

DNAJC13 Variants Show No Robust Association With Parkinson's Disease in a Multiancestry Cohort.

DNAJC13 Variants Show No Robust Association With Parkinson's Disease in a Multiancestry Cohort.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: January 14, 2026

EPIDEMIOLOGY OF LEVODOPA-INDUCED DYSKINESIA: PREVALENCE AND ASSOCIATED CLINICAL FACTORS IN LATIN AMERICA.

EPIDEMIOLOGY OF LEVODOPA-INDUCED DYSKINESIA: PREVALENCE AND ASSOCIATED CLINICAL FACTORS IN LATIN AMERICA.

Journal: medRxiv : the preprint server for health sciences

Published: September 05, 2025

Genotype-phenotype association study conducted on LARGE-PD reveals novel loci associated with Parkinson's Disease.

Genotype-phenotype association study conducted on LARGE-PD reveals novel loci associated with Parkinson's Disease.

Journal: medRxiv : the preprint server for health sciences

Published: August 12, 2025

DDOX expands the repertoire of tetracyclines for Parkinson's disease by preventing the cellular uptake and intracellular impact of α-synuclein preformed fibrils.

DDOX expands the repertoire of tetracyclines for Parkinson's disease by preventing the cellular uptake and intracellular impact of α-synuclein preformed fibrils.

Journal: Scientific reports

Published: January 23, 2025

Protein Coaggregation in Caribbean Atypical Parkinsonism: The Contribution of Annonacin.

Protein Coaggregation in Caribbean Atypical Parkinsonism: The Contribution of Annonacin.

Journal: Neuropathology and applied neurobiology

Published: September 18, 2024

Design, Synthesis, and Evaluation of a Novel Conjugate Molecule with Dopaminergic and Neuroprotective Activities for Parkinson's Disease.

Design, Synthesis, and Evaluation of a Novel Conjugate Molecule with Dopaminergic and Neuroprotective Activities for Parkinson's Disease.

Journal: ACS chemical neuroscience

Published: July 11, 2024

Humoral Immune Response to SARS-CoV-2 Vaccines in Patients with Autoimmune Rheumatic Diseases.

Humoral Immune Response to SARS-CoV-2 Vaccines in Patients with Autoimmune Rheumatic Diseases.

Journal: Archives of medical research

Published: April 17, 2024

Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound.

Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound.

Journal: Cells

Published: July 28, 2022

Humoral immunoresponse elicited against an adenoviral-based SARS-CoV-2 coronavirus vaccine in elderly patients.

Humoral immunoresponse elicited against an adenoviral-based SARS-CoV-2 coronavirus vaccine in elderly patients.

Journal: Aging

Published: May 20, 2022

Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina.

Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina.

Journal: Lancet regional health. Americas

Published: November 29, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026